BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

416 related articles for article (PubMed ID: 25866826)

  • 1. NADPH oxidase 4-derived H2O2 promotes aberrant retinal neovascularization via activation of VEGF receptor 2 pathway in oxygen-induced retinopathy.
    Li J; Wang JJ; Zhang SX
    J Diabetes Res; 2015; 2015():963289. PubMed ID: 25866826
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endothelial NADPH oxidase 4 mediates vascular endothelial growth factor receptor 2-induced intravitreal neovascularization in a rat model of retinopathy of prematurity.
    Wang H; Yang Z; Jiang Y; Hartnett ME
    Mol Vis; 2014; 20():231-41. PubMed ID: 24623966
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ROS-induced ROS release orchestrated by Nox4, Nox2, and mitochondria in VEGF signaling and angiogenesis.
    Kim YM; Kim SJ; Tatsunami R; Yamamura H; Fukai T; Ushio-Fukai M
    Am J Physiol Cell Physiol; 2017 Jun; 312(6):C749-C764. PubMed ID: 28424170
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of endoplasmic reticulum stress in 12/15-lipoxygenase-induced retinal microvascular dysfunction in a mouse model of diabetic retinopathy.
    Elmasry K; Ibrahim AS; Saleh H; Elsherbiny N; Elshafey S; Hussein KA; Al-Shabrawey M
    Diabetologia; 2018 May; 61(5):1220-1232. PubMed ID: 29468369
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of reactive oxygen species by Lovastatin downregulates vascular endothelial growth factor expression and ameliorates blood-retinal barrier breakdown in db/db mice: role of NADPH oxidase 4.
    Li J; Wang JJ; Yu Q; Chen K; Mahadev K; Zhang SX
    Diabetes; 2010 Jun; 59(6):1528-38. PubMed ID: 20332345
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiangiogenic effect of betaine on pathologic retinal neovascularization via suppression of reactive oxygen species mediated vascular endothelial growth factor signaling.
    Park SW; Jun HO; Kwon E; Yun JW; Kim JH; Park YJ; Kang BC; Kim JH
    Vascul Pharmacol; 2017 Mar; 90():19-26. PubMed ID: 27473515
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nox (NADPH Oxidase) 1, Nox4, and Nox5 Promote Vascular Permeability and Neovascularization in Retinopathy.
    Deliyanti D; Alrashdi SF; Touyz RM; Kennedy CR; Jha JC; Cooper ME; Jandeleit-Dahm KA; Wilkinson-Berka JL
    Hypertension; 2020 Apr; 75(4):1091-1101. PubMed ID: 32114846
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peroxisome proliferator-activated receptor gamma depletion stimulates Nox4 expression and human pulmonary artery smooth muscle cell proliferation.
    Bijli KM; Kleinhenz JM; Murphy TC; Kang BY; Adesina SE; Sutliff RL; Hart CM
    Free Radic Biol Med; 2015 Mar; 80():111-20. PubMed ID: 25557278
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NADPH oxidase 4 mediates insulin-stimulated HIF-1α and VEGF expression, and angiogenesis in vitro.
    Meng D; Mei A; Liu J; Kang X; Shi X; Qian R; Chen S
    PLoS One; 2012; 7(10):e48393. PubMed ID: 23144758
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endothelium-specific deletion of Nox4 delays retinal vascular development and mitigates pathological angiogenesis.
    Tang X; Wang JJ; Wang J; Abboud HE; Chen Y; Zhang SX
    Angiogenesis; 2021 May; 24(2):363-377. PubMed ID: 33201372
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thioredoxin-interacting protein deficiency ameliorates diabetic retinal angiogenesis.
    Duan J; Du C; Shi Y; Liu D; Ma J
    Int J Biochem Cell Biol; 2018 Jan; 94():61-70. PubMed ID: 29203232
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sustained Upregulation of Endothelial Nox4 Mediates Retinal Vascular Pathology in Type 1 Diabetes.
    Tang X; Wang J; Abboud HE; Chen Y; Wang JJ; Zhang SX
    Diabetes; 2023 Jan; 72(1):112-125. PubMed ID: 36321974
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of NADPH oxidase 1 and 4 blockade in activated human retinal endothelial cells.
    Appukuttan B; Ma Y; Stempel A; Ashander LM; Deliyanti D; Wilkinson-Berka JL; Smith JR
    Clin Exp Ophthalmol; 2018 Aug; 46(6):652-660. PubMed ID: 29360265
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nox4 supports proper capillary growth in exercise and retina neo-vascularization.
    Vogel J; Kruse C; Zhang M; Schröder K
    J Physiol; 2015 May; 593(9):2145-54. PubMed ID: 25652847
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NADPH oxidase 4 promotes cardiac microvascular angiogenesis after hypoxia/reoxygenation in vitro.
    Wang J; Hong Z; Zeng C; Yu Q; Wang H
    Free Radic Biol Med; 2014 Apr; 69():278-88. PubMed ID: 24480752
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nox4 is a protective reactive oxygen species generating vascular NADPH oxidase.
    Schröder K; Zhang M; Benkhoff S; Mieth A; Pliquett R; Kosowski J; Kruse C; Luedike P; Michaelis UR; Weissmann N; Dimmeler S; Shah AM; Brandes RP
    Circ Res; 2012 Apr; 110(9):1217-25. PubMed ID: 22456182
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand (TRAIL) Promotes Angiogenesis and Ischemia-Induced Neovascularization Via NADPH Oxidase 4 (NOX4) and Nitric Oxide-Dependent Mechanisms.
    Di Bartolo BA; Cartland SP; Prado-Lourenco L; Griffith TS; Gentile C; Ravindran J; Azahri NS; Thai T; Yeung AW; Thomas SR; Kavurma MM
    J Am Heart Assoc; 2015 Nov; 4(11):. PubMed ID: 26572549
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Both hydrogen peroxide and transforming growth factor beta 1 contribute to endothelial Nox4 mediated angiogenesis in endothelial Nox4 transgenic mouse lines.
    Chen L; Xiao J; Kuroda J; Ago T; Sadoshima J; Cohen RA; Tong X
    Biochim Biophys Acta; 2014 Dec; 1842(12 Pt A):2489-99. PubMed ID: 25315297
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NOX2, NOX4, and mitochondrial-derived reactive oxygen species contribute to angiopoietin-1 signaling and angiogenic responses in endothelial cells.
    Harel S; Mayaki D; Sanchez V; Hussain SNA
    Vascul Pharmacol; 2017 May; 92():22-32. PubMed ID: 28351775
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Apatinib, an Inhibitor of Vascular Endothelial Growth Factor Receptor 2, Suppresses Pathologic Ocular Neovascularization in Mice.
    Kim KL; Suh W
    Invest Ophthalmol Vis Sci; 2017 Jul; 58(9):3592-3599. PubMed ID: 28715845
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.